ZANETTO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.102
AS - Asia 5.652
EU - Europa 3.652
AF - Africa 1.565
SA - Sud America 1.363
OC - Oceania 166
Continente sconosciuto - Info sul continente non disponibili 67
Totale 21.567
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.223
SG - Singapore 2.191
BR - Brasile 841
CN - Cina 817
IT - Italia 811
HK - Hong Kong 653
VN - Vietnam 429
DE - Germania 288
FI - Finlandia 258
PL - Polonia 234
NL - Olanda 213
GB - Regno Unito 148
IN - India 143
SE - Svezia 141
FR - Francia 134
RU - Federazione Russa 129
MX - Messico 101
AR - Argentina 98
AT - Austria 96
TR - Turchia 87
ES - Italia 84
UA - Ucraina 72
ZA - Sudafrica 72
CA - Canada 71
KR - Corea 71
EC - Ecuador 70
ID - Indonesia 69
JP - Giappone 68
CO - Colombia 65
IE - Irlanda 64
IQ - Iraq 61
RO - Romania 59
PY - Paraguay 58
AE - Emirati Arabi Uniti 51
MA - Marocco 51
CR - Costa Rica 49
EG - Egitto 49
KG - Kirghizistan 49
LC - Santa Lucia 49
UG - Uganda 48
BE - Belgio 47
GT - Guatemala 47
SN - Senegal 47
BJ - Benin 46
HN - Honduras 46
JO - Giordania 46
PK - Pakistan 46
AO - Angola 45
CL - Cile 45
NO - Norvegia 45
PA - Panama 45
VE - Venezuela 45
AL - Albania 44
AZ - Azerbaigian 44
CI - Costa d'Avorio 44
CZ - Repubblica Ceca 44
GM - Gambi 44
IR - Iran 44
GR - Grecia 43
HR - Croazia 43
MD - Moldavia 43
TT - Trinidad e Tobago 43
BF - Burkina Faso 42
BW - Botswana 42
CH - Svizzera 42
CY - Cipro 42
ET - Etiopia 42
MG - Madagascar 42
NP - Nepal 42
BY - Bielorussia 41
CM - Camerun 41
MN - Mongolia 41
PR - Porto Rico 41
UY - Uruguay 41
AU - Australia 40
BA - Bosnia-Erzegovina 40
BB - Barbados 40
DZ - Algeria 40
LV - Lettonia 40
MU - Mauritius 40
TN - Tunisia 40
TZ - Tanzania 40
BS - Bahamas 39
GH - Ghana 39
KH - Cambogia 39
LY - Libia 39
MZ - Mozambico 39
SO - Somalia 39
TW - Taiwan 39
BG - Bulgaria 38
MK - Macedonia 38
SA - Arabia Saudita 38
TJ - Tagikistan 38
AM - Armenia 37
CV - Capo Verde 37
GE - Georgia 37
GP - Guadalupe 37
PE - Perù 37
PT - Portogallo 37
YE - Yemen 37
Totale 19.754
Salva come PNG Salva come JPEG
Città #
Singapore 1.140
Ashburn 1.077
Fairfield 946
New York 710
Hong Kong 621
Woodbridge 473
Houston 418
Chandler 395
Cambridge 324
Ann Arbor 306
Seattle 305
Wilmington 270
Beijing 246
Santa Clara 211
Boardman 200
Los Angeles 191
Padova 146
San Diego 140
Bytom 132
Helsinki 132
Ho Chi Minh City 123
Chicago 119
Medford 104
Princeton 104
Munich 102
Hanoi 89
São Paulo 84
Des Moines 80
Villafranca Padovana 72
Hefei 71
Milan 67
Warsaw 63
Roxbury 62
Buffalo 56
Vienna 53
Rome 51
Dong Ket 50
Dublin 50
Castries 47
Amman 46
Dakar 46
Kampala 46
Nuremberg 46
Cotonou 45
Salt Lake City 45
Baku 42
Panama City 42
Turku 42
Bishkek 41
Abidjan 40
London 40
Bridgetown 39
Ulan Bator 39
Antananarivo 38
Luanda 38
San José 38
Dushanbe 37
Lappeenranta 37
Nassau 36
Phnom Penh 36
Tokyo 36
Guangzhou 35
Johannesburg 35
Lusaka 35
Riga 35
Stockholm 35
Harare 34
Kigali 34
Montreal 34
Nanjing 34
Vientiane 34
Tampa 33
Accra 32
Brooklyn 32
Conakry 32
Managua 32
Ouagadougou 32
Redondo Beach 32
Shanghai 32
Gaborone 31
Montevideo 31
San Jose 31
Seoul 31
Tashkent 31
Praia 30
Rio de Janeiro 30
Addis Ababa 29
Dar es Salaam 29
Guatemala City 29
Papeete 29
Yerevan 29
Bamako 28
Kingstown 28
Maputo 28
Orem 28
Sanaa 28
Andorra la Vella 27
Auckland 27
Djibouti 27
Libreville 27
Totale 11.935
Salva come PNG Salva come JPEG
Nome #
Liver transplantation for viral hepatitis in 2015 563
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 272
Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study 258
Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma 236
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 210
Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease 206
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 199
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 197
New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation 196
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 196
Evolution of Liver Transplantation Indications: Expanding Horizons 194
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 194
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 192
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 190
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma 190
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 181
Markers of acute rejection and graft acceptance in liver transplantation. 181
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 181
Acute alcoholic hepatitis and liver transplantation: Waiting for Godot 177
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 175
Management of bacterial infection in the liver transplant candidate 174
Management of portal hypertension severe complications 174
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 172
ERS Statement on Benign Pleural Effusions in Adults 170
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 170
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 167
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 166
DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue? 165
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 165
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 164
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 163
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 161
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 160
Hepatitis C virus infection in end stage renal disease and kidney transplantation 159
PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 159
Current challenges and future directions for liver transplantation 158
Sex disparities in acute-on-chronic liver failure: From admission to the intensive care unit to liver transplantation 158
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 156
HCC criteria for liver transplantation: Controversies 155
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 155
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 154
Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) 153
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 153
Therapeutic approaches for portal biliopathy: A systematic review 152
Hepatocellular carcinoma in chronic viral hepatitis: Where do we stand? 152
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 149
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 149
Role of non-neoplastic portal vein thrombosis in the natural history of patients with cirrhosis and first diagnosis of hepatocellular carcinoma 148
Influence of donor and recipient gender on liver transplantation outcomes in Europe 148
Drug induced liver injury: from pathogenesis to liver transplantation 148
In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment 147
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients 147
Prevalence and risk factors of metabolic syndrome after liver transplantation: a single centre experience 147
Local prothrombotic state in portal venous system in cirrhosis 145
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 145
Recent advances in understanding and managing liver transplantation 143
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference 142
Hypercoagulability In Cirrhotic Patients With Hepatocellular Carcinoma (hcc) and Portal Vein Thrombosis (pvt) 142
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 139
Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation 138
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 136
EFFECTS OF NON-SELECTIVE beta-BLOCKERS ON HEMODYNAMICS AFTER LARGE VOLUME PARACENTESIS IN PATIENTS WITH CIRRHOSIS LISTED FOR LIVER TRANSPLANTATION: A PRELIMINARY REPORT 135
Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation 135
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. 134
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis 133
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates 133
Organ Preservation in Liver Transplantation 133
New indications for liver transplantation 131
Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) 130
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature 129
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 128
Hepatitis C virus and liver transplantation: Where do we stand? 126
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers 125
Timing for treatment of HCV recurrence after liver transplantation: the earlier the better. 125
Malnourished cirrhotic patient: what should we do? 124
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 124
Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis 123
Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis" 123
Response to: “Procedural bleeding in patients with cirrhosis: from prediction towards prevention” 120
Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients 120
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis 120
Liver Transplantation for NAFLD: indications and post-transplant management 120
Unusual-site thrombosis in patients with hazardous alcohol use: a narrative review 119
EASL-ERN Clinical Practice Guidelines on Wilson’s disease 119
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma 119
Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome 119
Hepatic immune regulation and sex disparities 118
Effect of Portal Vein Thrombosis (pvt) On Survival After Liver Transplantation (lt): A Metanalysis 118
Incidence and clinical significance of recompensation after HCV-cure 117
Patients with cirrhosis have a disbalance between coagulation and fibrinolysis resulting in a prothrombotic phenotype 116
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 115
Effects of Non-Selective beta-Blockers on Hemodynamics and Paracentesis Induced Circulatory Dysfunction in Patients with Cirrhosis Undergoing Large Volume Paracentesis: a Preliminary Report 115
An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know 114
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma 113
Multiple hepatic cysts in an adult male 110
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension 110
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 110
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 107
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 107
Long-term care of transplant recipients: de novo neoplasms after liver transplantation 107
Totale 15.460
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.554
article - articoli 66.179
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.733
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021572 0 0 0 0 0 0 52 66 111 86 88 169
2021/20221.471 64 126 129 98 39 167 129 123 60 81 122 333
2022/2023941 196 80 36 72 159 102 26 59 108 5 80 18
2023/2024903 61 102 92 77 60 96 92 36 40 62 90 95
2024/20254.251 11 272 176 155 424 118 267 297 419 228 708 1.176
2025/202611.190 954 1.273 2.794 3.039 1.590 1.456 84 0 0 0 0 0
Totale 21.858